Marie-Claude Proulx
University of Calgary
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marie-Claude Proulx.
The American Journal of Gastroenterology | 2012
Gilaad G. Kaplan; Cynthia H. Seow; Subrata Ghosh; Natalie A. Molodecky; Ali Rezaie; Gordon W. Moran; Marie-Claude Proulx; James Hubbard; Anthony R. MacLean; Donald Buie; Remo Panaccione
OBJECTIVES:Colectomy rates for ulcerative colitis (UC) have been inconsistently reported. We assessed temporal trends of colectomy rates for UC, stratified by emergent vs. elective colectomy indication.METHODS:From 1997 to 2009, we identified adults hospitalized for a flare of UC. Medical charts were reviewed. Temporal changes were evaluated using linear regression models to estimate the average annual percent change (AAPC) in surgical rates. Logistic regression analysis compared: (i) UC patients responding to medical management in hospital to those who underwent colectomy; (ii) UC patients who underwent an emergent vs. elective colectomy; and (iii) temporal trends of drug utilization.RESULTS:From 1997 to 2009, colectomy rates significantly dropped for elective colectomies with an AAPC of −7.4% (95% confidence interval (CI): −10.8%, −3.9%). The rate of emergent colectomies remained stable with an AAPC of −1.4% (95% CI: −4.8%, 2.0%). Azathioprine/6-mercaptopurine prescriptions increased from 1997 to 2009 (odds ratio (OR)=1.15; 95% CI: 1.09–1.22) and infliximab use increased after 2005 (OR=1.68; 95% CI: 1.25–2.26). A 13% per year risk adjusted reduction in the odds of colectomy (OR=0.87; 95% CI: 0.83–0.92) was observed in UC patients responding to medical management compared with those who required colectomy. Emergent colectomy patients had a shorter duration of flare (<2 weeks vs. 2–8 weeks, OR=5.31; 95% CI: 1.58–17.81) and underwent colectomy early after diagnosis (<1 year vs. 1–3 years, OR=5.48; 95% CI: 2.18–13.79).CONCLUSIONS:From 1997 to 2009, use of purine anti-metabolites increased and elective colectomy rates in UC patients decreased significantly. In contrast, emergent colectomy rates were stable, which may have been due to rapid progression of disease activity.
Journal of Pediatric Gastroenterology and Nutrition | 2012
Ing Shian Soon; Iwona Wrobel; Jennifer deBruyn; Reg Sauve; David L. Sigalet; Belle S. Kaplan; Marie-Claude Proulx; Gilaad G. Kaplan
Background and Aims: Colectomy rates for ulcerative colitis (UC) and data on postcolectomy complications in children are limited. Thus, we assessed colectomy rates, early postcolectomy complications, and clinical predictors in children with UC undergoing a colectomy. Methods: Children (18 years old or older) with UC who underwent colectomy from 1983 to 2009 were identified (n = 30). All of the medical charts were reviewed. The diagnostic accuracy of International Classification of Diseases codes for UC and colectomy were validated. The primary outcome was postoperative complications defined as Clavien-Dindo classification grade II or higher. The yearly incidence of colectomies for pediatric UC was calculated and temporal trends were evaluated. Results: The sensitivity and positive predictive value of UC and colectomy International Classification of Diseases codes were 96% and 100%, respectively. The median ages at UC diagnosis and colectomy were 10.9 and 12.1 years, respectively. All of the children had pancolitis and 63% underwent emergent colectomy. Postoperatively, 33% experienced at least 1 complication. Patients with emergent colectomy were more likely to have a postoperative complication compared with patients with elective colectomy (90% vs 50%; P = 0.03). For emergent colectomy, postoperative complications were associated with a disease flare of ≥2 weeks before admission (60% vs 0%; P = 0.03) and >2 weeks from admission to colectomy (78% vs 22%; P = 0.04). The average annual rate of pediatric colectomy was 0.059/100,000 person-years and stable from 1983 to 2009 (P > 0.05). Conclusions: Colectomy UC was uncommon and rates have remained stable. Postcolectomy complications were common, especially in patients undergoing emergent colectomy. Optimizing timing of colectomy may reduce postoperative complications.
BMC Gastroenterology | 2012
Christopher Ma; Marcelo Crespin; Marie-Claude Proulx; Shanika DeSilva; James Hubbard; Martin Prusinkiewicz; Geoffrey C. Nguyen; Remo Panaccione; Subrata Ghosh; Robert P. Myers; Hude Quan; Gilaad G. Kaplan
BackgroundUlcerative colitis (UC) patients failing medical management require colectomy. This study compares risk estimates for predictors of postoperative complication derived from administrative data against that of chart review and evaluates the accuracy of administrative coding for this population.MethodsHospital administrative databases were used to identify adults with UC undergoing colectomy from 1996–2007. Medical charts were reviewed and regression analyses comparing chart versus administrative data were performed to assess the effect of age, emergent operation, and Charlson comorbidities on the occurrence of postoperative complications. Sensitivity, specificity, and positive/negative predictive values of administrative coding for identifying the study population, Charlson comorbidities, and postoperative complications were assessed.ResultsCompared to chart review, administrative data estimated a higher magnitude of effect for emergent admission (OR 2.52 [95% CI: 1.80–3.52] versus 1.49 [1.06–2.09]) and Charlson comorbidities (OR 2.91 [1.86–4.56] versus 1.50 [1.05–2.15]) as predictors of postoperative complications. Administrative data correctly identified UC and colectomy in 85.9% of cases. The administrative database was 37% sensitive in identifying patients with ≥ 1Charlson comorbidity. Restricting analysis to active comorbidities increased the sensitivity to 63%. The sensitivity of identifying patients with at least one postoperative complication was 68%; restricting analysis to more severe complications improved the sensitivity to 84%.ConclusionsAdministrative data identified the same risk factors for postoperative complications as chart review, but overestimated the magnitude of risk. This discrepancy may be explained by coding inaccuracies that selectively identifying the most serious complications and comorbidities.
Canadian Journal of Gastroenterology & Hepatology | 2015
Stephanie Coward; Steven J. Heitman; Fiona Clement; James Hubbard; Marie-Claude Proulx; Scott Zimmer; Remo Panaccione; Cynthia H. Seow; Yvette Leung; Indraneel Datta; Subrata Ghosh; Robert P. Myers; Mark G. Swain; Gilaad G. Kaplan
BACKGROUND Hospitalization costs for ulcerative colitis (UC) following the introduction of infliximab have not been evaluated. OBJECTIVE To study predictors of costs for UC patients who were hospitalized for a flare or colectomy. METHODS Population-based surveillance identified adults (≥18 years of age) admitted to hospital for UC flare or colectomy between 2001 and 2009 in the Calgary Health Zone (Alberta). Medical charts were reviewed and patients stratified into three admission types: responsive to inpatient medical therapy (n=307); emergent colectomy (n=227); and elective colectomy (n=208). The annual median cost with interquartile range (IQR) was calculated. Linear regression determined the effect of admission type on hospital charges after adjusting for age, sex, smoking, comorbidities, disease extent, medication use (eg, infliximab) and year. The adjusted cost increase was presented as the percent increase with 95% CIs. Joinpoint analysis assessed for an inflection point in hospital cost after the introduction of infliximab. RESULTS Median hospitalization cost for UC flare, emergent colectomy and elective colectomy, respectively, were:
Gastroenterology | 2011
Rahim Kachra; Murad Bandali; Marie-Claude Proulx; Allen Lim; James Hubbard; Remo Panaccione; Subrata Ghosh; Gilaad G. Kaplan
5,499 (IQR
Gastroenterology | 2013
Yvette Leung; Gilaad G. Kaplan; Stephanie Coward; Marie-Claude Proulx; Divine Tanyingoh; Subrata Ghosh; Remo Panaccione; Cynthia H. Seow
3,374 to
Gastroenterology | 2011
Allen Lim; Marie-Claude Proulx; James Hubbard; Shanika de Silva; Remo Panaccione; Shane M. Devlin; Cynthia H. Seow; Yvette Leung; Subrata Ghosh; Gilaad G. Kaplan
8,904),
Gastroenterology | 2013
Meena Mathivanan; Cynthia H. Seow; Gilaad G. Kaplan; Marie-Claude Proulx; Divine Tanyingoh; Remo Panaccione; Subrata Ghosh; Yvette Leung
23,698 (IQR
Gastroenterology | 2012
Michael J. Diamant; William D. Buie; Anthony R. MacLean; Elijah Dixon; Chad G. Ball; Marie-Claude Proulx; Gilaad G. Kaplan
17,981 to
Gastroenterology | 2011
Samuel Quan; Natalie A. Molodecky; Alexandra D. Frolkis; Marie-Claude Proulx; Eddy Lang; Robert P. Myers; Martin Storr; Gilaad G. Kaplan
32,385) and